Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Thompson

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Cancer Research|May 19, 2001
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancerS A Tahir, G Yang, S Ebara, et al.
Cancer Gene Therapy|March 17, 1999
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerS J Hall, S E Mutchnik, G Yang, et al.
Molecular Endocrinology (Baltimore, Md.)|April 1, 1991
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progressionV W Merz, G J Miller, T Krebs, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2005
The emerging role of the PI3-K-Akt pathway in prostate cancer progressionL Li, M M Ittmann, G Ayala, et al.
Expert Opinion on Biological Therapy|December 1, 2001
In situ gene therapy for prostate cancer: immunomodulatory approachesT C Thompson, T L Timme, S Ebara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical studyR H Williams, A M Stapleton, G Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Association of p53 mutations with metastatic prostate cancerJ A Eastham, A M Stapleton, A E Gousse, et al.
International Journal of Cancer|January 27, 1995
DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancerD R Greene, S R Taylor, M Aihara, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2001
Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor modelM T Vlachaki, M Chhikara, L Aguilar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancerS W Sukin, M Chhikara, X Zhu, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Cancer Research|May 19, 2001
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancerS A Tahir, G Yang, S Ebara, et al.
Cancer Gene Therapy|March 17, 1999
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerS J Hall, S E Mutchnik, G Yang, et al.
Molecular Endocrinology (Baltimore, Md.)|April 1, 1991
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progressionV W Merz, G J Miller, T Krebs, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2005
The emerging role of the PI3-K-Akt pathway in prostate cancer progressionL Li, M M Ittmann, G Ayala, et al.
Expert Opinion on Biological Therapy|December 1, 2001
In situ gene therapy for prostate cancer: immunomodulatory approachesT C Thompson, T L Timme, S Ebara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical studyR H Williams, A M Stapleton, G Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Association of p53 mutations with metastatic prostate cancerJ A Eastham, A M Stapleton, A E Gousse, et al.
International Journal of Cancer|January 27, 1995
DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancerD R Greene, S R Taylor, M Aihara, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2001
Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor modelM T Vlachaki, M Chhikara, L Aguilar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancerS W Sukin, M Chhikara, X Zhu, et al.
Pageof 13